Biocon Ltd.
NSE: BIOCON | BSE: 532523
₹412.30
₹-3.75
(-0.90%)
As on 05-Jun-2026IST
Market cap
₹66,790 Cr
Revenue (TTM)
₹16,927 Cr
P/E Ratio
173.2
P/B Ratio
2
Div. Yield
0.1 %
Quality Score
2/10
Growth Score
6/10
Valuation Score
3/10
Momentum Score
8/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹386 Cr
-
ROE
7 %
-
ROCE
7.4 %
-
Industry P/E
35.23
-
EV/EBITDA
20.6
-
Debt to Equity
0.3
-
Book Value
₹210
-
EPS
₹-1.6
-
Face value
5
-
Shares outstanding
1,620,907,773
10 Years Aggregate
CFO
₹15,314.30 Cr
EBITDA
₹15,631.90 Cr
Net Profit
₹8,640.70 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Biocon
| 4.7 | 14.3 | 9.0 | 22.6 | 19.7 | 1.4 | 13.4 |
|
BSE Healthcare
| 8.0 | 3.6 | 8.8 | 9.9 | 24.9 | 13.6 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Biocon
| 6.8 | 43.0 | -4.7 | -28.2 | -21.7 | 58.0 | -6.1 |
|
BSE Mid Cap
| 1.1 | 25.8 | 45.5 | 1.4 | 39.2 | 19.9 | -3.0 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Biocon
|
412.3 | 66,789.5 | 16,927.0 | 368.8 | 8.8 | -0.6 | 173.2 | 2.0 |
| 26,035.0 | 55,285.7 | 6,929.1 | 1,552.0 | 26.2 | 35.3 | 35.6 | 11.6 | |
| 5,251.5 | 62,786.6 | 14,712.3 | 2,353.1 | 17.8 | 17.7 | 27.3 | 4.5 | |
| 1,462.3 | 84,151.9 | 33,653.1 | 3,501.5 | 14.9 | 9.7 | 24 | 2.2 | |
| 2,164.1 | 36,698.4 | 3,821.7 | 1,036.0 | 32.5 | 48.8 | 35.4 | 16.1 | |
| 1,641.9 | 41,684.9 | 9,646.3 | 1,191.4 | 16.2 | 15.5 | 36.5 | 5.2 | |
| 2,267.7 | 1,03,704.9 | 27,958.0 | 5,355.5 | 26.6 | 27.4 | 19.4 | 4.6 | |
| 2,336.1 | 96,492.8 | 14,277.6 | 1,926.4 | 19.1 | 12.8 | 50.4 | 5.9 | |
| 1,782.2 | 4,27,933.4 | 58,462.0 | 11,564.5 | 23.9 | 15.4 | 37.3 | 5.1 | |
| 1,089.0 | 1,09,568.8 | 27,148.4 | 5,026.4 | 21.9 | 20.7 | 21.7 | 4.0 |
Shareholding Pattern
View DetailsNews & Analysis
All News
1 min read•By Research Desk
2 min read•By Value Research
5 min read•By Research Desk
2 min read•By Research Desk
About Biocon
Biocon Limited, together with its subsidiaries, manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics, Biosimilars, and... Research segments. The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, multiple sclerosis, anti-fungal, anti-cancer, immunosuppressants, and specialty molecules; and biosimilars products consisting of pegfilgrastim, trastuzumab, bevacizumab, adalimumab, etanercept, ustekinumab, glargine, aspart, insulins, and aflibercept. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer goods, and agrochemical companies. In addition, the company offers enzyme, biopharmaceutical, and medicinal goods; contract research and manufacturing services, and other research and development in the fields of pharmaceuticals, drug discovery, biotechnology pharmaceuticals, and medicinal sciences, etc.; clinical research; and business support and development, and marketing services. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India. Read more
-
Incorporated
1978
-
Chairman
Kiran Mazumdar-Shaw
-
Managing Director
--
-
Headquarters
Bengaluru, Karnataka
-
Website
Looking for more details about Biocon Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Biocon
What is the current share price of Biocon Ltd Today?
The share price of Biocon Ltd is ₹412.30 (NSE) and ₹412.05 (BSE) as of 05-Jun-2026 IST. Biocon Ltd has given a return of 19.72% in the last 3 years.
What is the current PB & PE ratio of Biocon Ltd?
The P/E ratio of Biocon Ltd is 173.21 times as on 05-Jun-2026, a 392 premium to its peers’ median range of 35.23 times.
The P/B ratio of Biocon Ltd is 1.96 times as on 05-Jun-2026, a 58 discount to its peers’ median range of 4.62 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
40.43
|
1.93
|
|
2024
|
31.01
|
1.63
|
|
2023
|
53.54
|
1.41
|
|
2022
|
61.95
|
4.88
|
|
2021
|
66.25
|
6.57
|
What is the 52 Week High and Low of Biocon Ltd?
The 52-week high and low of Biocon Ltd are Rs 440.40 and Rs 327.60 as of 07-Jun-2026.
What is the market cap of Biocon Ltd?
Biocon Ltd has a market capitalisation of ₹ 66,790 Cr as on 05-Jun-2026. As per SEBI classification, it is a Mid Cap company.
Should I invest in Biocon Ltd?
Before investing in Biocon Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.